BioCryst Pharmaceuticals
BCRX
#5073
Rank
A$2.40 B
Marketcap
A$11.43
Share price
-3.07%
Change (1 day)
-3.90%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total assets

Total assets on the balance sheet as of September 2025 : A$0.67 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total assets are A$0.67 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BioCryst Pharmaceuticals - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31A$0.78 B3.91%
2023-12-31A$0.75 B-6.12%
2022-12-31A$0.80 B-0.37%
2021-12-31A$0.81 B86.37%
2020-12-31A$0.43 B73.87%
2019-12-31A$0.25 B20.11%
2018-12-31A$0.20 B-8.71%
2017-12-31A$0.22 B83.19%
2016-12-31A$0.12 B-25.79%
2015-12-31A$0.16 B0.43%
2014-12-31A$0.16 B205.29%
2013-12-31A$54.78 M-0.88%
2012-12-31A$55.27 M-31.06%
2011-12-31A$80.17 M-25.59%
2010-12-31A$0.10 B-31.93%
2009-12-31A$0.15 B31.86%
2008-12-31A$0.12 B-26.46%
2007-12-31A$0.16 B87.9%
2006-12-31A$86.87 M-35.95%
2005-12-31A$0.13 B223.28%
2004-12-31A$41.95 M3.63%
2003-12-31A$40.48 M-44.77%
2002-12-31A$73.3 M-36.69%
2001-12-31A$0.11 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Repligen
RGEN
A$4.40 B 554.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
A$5.25 B 682.54%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
A$13.28 M-98.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$1.77 B 164.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
A$88.12 B 13,011.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$0.97 B 45.25%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$124.14 B 18,371.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
A$2.19 B 227.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A$30.61 M-95.44%๐Ÿ‡บ๐Ÿ‡ธ USA